絞り込み

16545

広告

7364件中 81件~100件表示    検索結果をPubMedで見る PubMedで見る

STIM promotes the epithelial-mesenchymal transition of podocytes through regulation of FcγRII activity in diabetic nephropathy.

Mitotic Catastrophe Causes Podocyte Loss in the Urine of Human Diabetics.

MYH9 Associated nephropathy.

Awakening the Bowman: inhibition of CXCL12 signaling activates parietal epithelial cells.

Neurofilament heavy polypeptide protects against reduction in synaptopodin expression and prevents podocyte detachment.

Expression of DENDRIN in several glomerular diseases and correlation to pathological parameters and renal failure - preliminary study.

Targeted gene panel for genetic testing of south Indian children with steroid resistant nephrotic syndrome.

Minimal change nephrotic syndrome in patients infected with human immunodeficiency virus: a retrospective study of 8 cases.

Anti-Bovine Podoplanin Monoclonal Antibody PMab-44 Detects Goat Podoplanin in Immunohistochemistry.

Interleukin-7 stimulation inhibits nephrin activation and induces podocyte injury.

The TRPC6-AMPK Pathway is Involved in Insulin-Dependent Cytoskeleton Reorganization and Glucose Uptake in Cultured Rat Podocytes.

Unmet challenges in membranous nephropathy.

Weighted Gene Correlation Network Analysis (WGCNA) Detected Loss of MAGI2 Promotes Chronic Kidney Disease (CKD) by Podocyte Damage.

Akt2 causes TGFβ-induced deptor downregulation facilitating mTOR to drive podocyte hypertrophy and matrix protein expression.

Changes in cell fate determine the regenerative and functional capacity of the developing kidney before and after release of obstruction.

Expression of CMIP in podocytes is restricted to specific classes of lupus nephritis.

Celastrol antagonizes high glucose-evoked podocyte injury, inflammation and insulin resistance by restoring the HO-1-mediated autophagy pathway.

Characterization of autoantibodies in primary membranous nephropathy and their clinical significance.

CXCL12 limits podocyte regeneration.

MiR-27b regulates podocyte survival through targeting adenosine receptor 2B in podocytes from non-human primate.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります